Divalproex Sodium 500 mg/1 (Divalproex Sodium TABLET, FILM COATED, EXTENDED RELEASE) 500 mg/1

Divalproex sodium 500 mg extended-release tablets are used to manage certain types of seizures and mood disorders. This medication helps stabilize mood and prevent seizures by affecting brain chemistry.

Strength

500 mg/1

Pack Size

500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (29300-381-05)

Manufacturer / TM Owner

Unichem Pharmaceuticals (USA), Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Divalproex sodium is primarily used to treat epilepsy and bipolar disorder. It is often prescribed for managing seizures and stabilizing mood swings associated with bipolar disorder. The extended-release form helps maintain consistent levels of the medication in the body.

Side Effects

Common effects of divalproex sodium may include drowsiness, dizziness, and nausea. Some users may experience weight changes or tremors. These effects can vary and may not affect everyone in the same way.

Precautions & Warnings

Divalproex sodium should be handled with care, especially for those with liver or pancreatic conditions. Regular monitoring by a healthcare provider is recommended. Always follow the prescribed dosage and consult a healthcare professional before making any changes.

Avoid Interactions

Divalproex sodium can interact with other medications, including certain antidepressants, anticonvulsants, and drugs that affect liver enzymes. Alcohol should be avoided as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Divalproex sodium is used to treat epilepsy and bipolar disorder, helping to manage seizures and stabilize mood.

Divalproex sodium should be taken orally, usually once or twice a day, with or without food. Follow the instructions provided by your healthcare provider.

Common side effects include drowsiness, dizziness, nausea, and weight changes. Always consult a healthcare provider for personalized advice.

Divalproex sodium can interact with other medications, so it's important to inform your healthcare provider about all medications you are taking.

Divalproex sodium may not be suitable for everyone, especially those with liver or pancreatic conditions. Always consult a healthcare provider before starting this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.